pirfenidone has been researched along with Proliferative Vitreoretinopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basak, SK; Guha, R; Hazra, S; Khanum, BNMK; Konar, A; Nandi, S; Sur, VP | 1 |
| Choi, C; Choi, K; Im, M; Kook, KH; Lee, K; Ryu, SW | 1 |
2 other study(ies) available for pirfenidone and Proliferative Vitreoretinopathy
| Article | Year |
|---|---|
Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy.
Topics: Actins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Collagen Type I; Cytokines; Disease Models, Animal; Electroretinography; Eye Injuries, Penetrating; Fluorescent Antibody Technique, Indirect; Gene Expression Regulation; Intravitreal Injections; Pyridones; Rabbits; Real-Time Polymerase Chain Reaction; Retina; Vitreoretinopathy, Proliferative; Vitreous Body | 2017 |
Pirfenidone inhibits transforming growth factor-β1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19.
Topics: Actins; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Cell Line; Cell Movement; Collagen; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Fibronectins; Fibrosis; Gene Expression; Humans; JNK Mitogen-Activated Protein Kinases; Protein Transport; Pyridones; Retinal Pigment Epithelium; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1; Vitreoretinopathy, Proliferative | 2012 |